Literature DB >> 30043912

Lidocaine and Pinacidil Added to Blood versus Crystalloid Cardioplegic Solutions: Study in Isolated Hearts.

Helison Pereira do Carmo1, Karla Reichert1, Daniela Diógenes de Carvalho1, Lindemberg da Mota Silveira-Filho1, Karlos Vilarinho1, Pedro Oliveira1, Orlando Petrucci1.   

Abstract

OBJECTIVE: The present study aimed the functional recovery evaluation after long term of cardiac arrest induced by Custodiol (crystalloid-based) versus del Nido (blood-based) solutions, both added lidocaine and pinacidil as cardioplegic agents. Experiments were performed in isolated rat heart perfusion models.
METHODS: Male rat heart perfusions, according to Langendorff technique, were induced to cause 3 hours of cardiac arrest with a single dose. The hearts were assigned to one of the following three groups: (I) control; (II) Custodiol-LP; and (III) del Nido-LP. They were evaluated after ischemia throughout 90 minutes of reperfusion. Left ventricular contractility function was reported as percentage of recovery, expressed by developed pressure, maximum dP/dt, minimum dP/dt, and rate pressure product variables. In addition, coronary resistance and myocardial injury marker by alpha-fodrin degradation were also evaluated.
RESULTS: At 90 minutes of reperfusion, both solutions had superior left ventricular contractile recovery function than the control group. Del Nido-LP was superior to Custodiol-LP in maximum dP/dt (46%±8 vs. 67%±7, P<0.05) and minimum dP/dt (31%±4 vs. 51%±9, P<0.05) variables. Coronary resistance was lower in del Nido-LP group than in Custodiol-LP (395%±50 vs. 307%±13, P<0.05), as well as alpha-fodrin degradation, with lower levels in del Nido-LP group (P<0.05).
CONCLUSION: Del Nido-LP cardioplegia showed higher functional recovery after 3 hours of ischemia. The analysis of alpha-fodrin degradation showed del Nido-LP solution provided greater protection against myocardial ischemia and reperfusion (IR) in this experimental model.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30043912      PMCID: PMC6089128          DOI: 10.21470/1678-9741-2017-0244

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


  22 in total

1.  First results of the multicenter study of HTK protection for kidney transplants.

Authors:  A F Groenewoud; B Buchholz; F Gubernatis; M Hölscher; J Hoyer; F Isemer; W Niebel; H Wilms
Journal:  Transplant Proc       Date:  1990-10       Impact factor: 1.066

Review 2.  Cardiac ATP-sensitive potassium channels: a potential target for an anti-ischaemic pharmacological strategy.

Authors:  L Testai; S Rapposelli; V Calderone
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-01

Review 3.  Current status of the HTK solution of Bretschneider in organ preservation.

Authors:  M Hölscher; A F Groenewoud
Journal:  Transplant Proc       Date:  1991-10       Impact factor: 1.066

4.  Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.

Authors:  Hiroshi Yamamoto; Fumio Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-23

5.  Calpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion.

Authors:  Víctor Hernando; Javier Inserte; Carmem Luíza Sartório; Víctor M Parra; Marcos Poncelas-Nozal; David Garcia-Dorado
Journal:  J Mol Cell Cardiol       Date:  2010-03-06       Impact factor: 5.000

6.  Superior myocardial preservation with HTK solution over Celsior in rat hearts with prolonged cold ischemia.

Authors:  Sungsoo Lee; Chien-Sheng Huang; Tomohiro Kawamura; Norihisa Shigemura; Donna B Stolz; Timothy R Billiar; James D Luketich; Atsunori Nakao; Yoshiya Toyoda
Journal:  Surgery       Date:  2010-06-02       Impact factor: 3.982

Review 7.  Evidence-based medicine and myocardial protection--where is the evidence?

Authors:  Z G Ferguson; D E Yarborough; B L Jarvis; J J Sistino
Journal:  Perfusion       Date:  2014-10-08       Impact factor: 1.972

8.  Calpain and mitochondria in ischemia/reperfusion injury.

Authors:  Min Chen; Dong-Jun Won; Stan Krajewski; Roberta A Gottlieb
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

9.  Neonatal life-threatening arrhythmia responding to lidocaine, a probable LQTS3.

Authors:  Pedro Betrián Blasco; María Isabel Antúnez Jiménez; Luis Hipólito Falcón González; Pedro Suárez Cabrera
Journal:  Int J Cardiol       Date:  2007-02-22       Impact factor: 4.164

10.  Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism.

Authors:  Karla Reichert; Helison Rafael Pereira do Carmo; Anali Galluce Torina; Daniela Diógenes de Carvalho; Andrei Carvalho Sposito; Karlos Alexandre de Souza Vilarinho; Lindemberg da Mota Silveira-Filho; Pedro Paulo Martins de Oliveira; Orlando Petrucci
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

View more
  2 in total

1.  Comment on "Lidocaine and pinacidil added to blood versus crystalloid cardioplegic solutions: study in isolated hearts".

Authors:  Claus J Preusse
Journal:  Braz J Cardiovasc Surg       Date:  2018 Nov-Dec

2.  del Nido cardioplegia in surgery for aortic root disease: a historically controlled study.

Authors:  Hui Shi; Haiyan Luo; Xiaomin Qi; Hui Zhao; Chaoqi Liu; Hongsong Chen; Runsheng Peng; Zhangsheng Yu; Kejian Hu; Xin Li; Chunsheng Wang
Journal:  J Thorac Dis       Date:  2020-08       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.